LLY

902.74

-0.9%↓

UNH

596.8

+0.31%↑

NVO

131.05

+0.18%↑

JNJ

164.37

-0.29%↓

ABBV

193.18

+0.34%↑

LLY

902.74

-0.9%↓

UNH

596.8

+0.31%↑

NVO

131.05

+0.18%↑

JNJ

164.37

-0.29%↓

ABBV

193.18

+0.34%↑

LLY

902.74

-0.9%↓

UNH

596.8

+0.31%↑

NVO

131.05

+0.18%↑

JNJ

164.37

-0.29%↓

ABBV

193.18

+0.34%↑

LLY

902.74

-0.9%↓

UNH

596.8

+0.31%↑

NVO

131.05

+0.18%↑

JNJ

164.37

-0.29%↓

ABBV

193.18

+0.34%↑

LLY

902.74

-0.9%↓

UNH

596.8

+0.31%↑

NVO

131.05

+0.18%↑

JNJ

164.37

-0.29%↓

ABBV

193.18

+0.34%↑

Search

Charles River Laboratories International Inc

Suletud

Sektor Tervishoid

187.55 -1.68

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

186.83

Max

187.85

Põhinäitajad

By Trading Economics

Sissetulek

27M

94M

Müük

20M

1B

P/E

Sektori keskmine

24.27

103.001

Aktsiakasum

2.8

Kasumimarginaal

9.134

Töötajad

20,000

EBITDA

19M

239M

Soovitused

By TipRanks

Soovitused

Osta

12 kuu keskmine prognoos

+15.59 upside

Turustatistika

By TradingEconomics

Turukapital

33M

10B

Eelmine avamishind

189.23

Eelmine sulgemishind

187.55

Uudiste sentiment

By Acuity

50%

50%

114 / 365 Pingereas Healthcare

Tehniline skoor

By Trading Central

Kindlus

Bearish Evidence

Charles River Laboratories International Inc Graafik

Seotud uudised

8. aug 2024, 10:30 UTC

Peamised uudised

Big Pharma Cuts R&D, Sending Shudders Through Industry -- Heard on the Street -- WSJ

23. märts 2024, 13:00 UTC

Peamised uudised

U.S.-China Decoupling Poses Supply-Chain Risks for Drug Companies -- Heard on the Street -- WSJ

Võrdlus sarnastega

Hinnamuutus

Charles River Laboratories International Inc Prognoos

Hinnasiht

By TipRanks

15.59% tõus

12 kuu keskmine prognoos

Keskmine 221 USD  15.59%

Kõrge 250 USD

Madal 191 USD

Põhineb 11 Wall Streeti analüütiku instrumendi Charles River Laboratories International Inc 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Osta

11 ratings

4

Osta

7

Hoia

0

Müü

Tehniline skoor

By Trading Central

187.1 / 191.4Toetus ja vastupanu

Lühikene perspektiiv

Bearish Evidence

Keskpikk perspektiiv

Very Strong Bearish Evidence

Pikk perspektiiv

Very Strong Bearish Evidence

Sentiment

By Acuity

114 / 365 Pingereas Tervishoid

Uudiste sentiment

Neutral

Volatiilsus

Alla keskmise

Uudismaht (RCV)

Alla keskmise

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

$

Ettevõttest Charles River Laboratories International Inc

Charles River Laboratories International, Inc. is a full service, early-stage contract research company. The Company provides products and services to help pharmaceutical and biotechnology companies, government agencies and academic institutions in research and drug development. The Company operates through two segments: Discovery and Safety Assessment (DSA) and Manufacturing Solutions (Manufacturing). The DSA segment includes services required to take a drug through the early development process including discovery services, which are non-regulated services to assist clients with the identification, screening, and selection of a lead compound for drug development, and regulated and non-regulated (Good Laboratory Practice (GLP) and non-GLP) safety assessment services. The Manufacturing segment includes Microbial Solutions, Biologics Solutions, and Avian Vaccine Services.